Institutional
General Catalyst Group Management, LLC
CIK 0001637946
$183.6M
Reported AUM
12
Positions
Q1 2026
Period
2026-05-15
Filed
The Brief · General Catalyst Group Management, LLC · Q1 2026
AI · grounded in 13F
General Catalyst Group Management, LLC established a new position in EIKN valued at $3.2M. The fund also added five new positions to its portfolio, including LIFE at $828,579 and CPNG at $692,462. Other new entries include AMZN and META. The fund reduced no existing positions during the period.
Portfolio · Q1 2026
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IOT | SAMSARA INC | $38.75 | 3.33% | 7.61% | 114.09% | $63.4M | 34.53% | — | HELD |
| 2 | AVBP | ARRIVENT BIOPHARMA INC | $30.04 | 0.20% | 60.99% | 39.46% | $34.5M | 18.79% | — | HELD |
| 3 | MAZE | MAZE THERAPEUTICS INC | $27.27 | -2.19% | 83.02% | 122.98% | $30.9M | 16.85% | — | HELD |
| 4 | CART | MAPLEBEAR INC | $45.64 | 0.04% | -2.91% | 85.30% | $26.6M | 14.50% | — | HELD |
| 5 | GTLB | GITLAB INC | $34.03 | 3.23% | -18.02% | -64.49% | $19.9M | 10.86% | — | HELD |
| 6 | EIKN | EIKON THERAPEUTICS INC | $9.01 | -5.06% | -37.86% | -14.84% | $3.2M | 1.76% | — | HELD |
| 7 | GUTS | FRACTYL HEALTH INC | $0.69 | -4.56% | -61.88% | -90.68% | $2.2M | 1.22% | — | HELD |
| 8 | LIFE | ETHOS TECHNOLOGIES INC | $19.84 | 5.53% | 31.83% | 60.65% | $829K | 0.45% | — | HELD |
| 9 | CPNG | COUPANG INC | $15.16 | -1.81% | -47.25% | -49.40% | $692K | 0.38% | — | HELD |
| 10 | AMZN | AMAZON COM INC | $226.65 | -1.82% | 5.54% | 30.60% | $538K | 0.29% | — | HELD |
| 11 | META | META PLATFORMS INC | $585.61 | -1.31% | -21.66% | 55.72% | $376K | 0.21% | — | HELD |
| 12 | FIG | FIGMA INC | $24.76 | 1.56% | -79.70% | -64.77% | $314K | 0.17% | — | HELD |
Source: SEC EDGAR · accession 0000905148-26-002373. 13F discloses long positions only — shorts, foreign equities, and options are excluded.